PremiumRatingsTriSalus Life Sciences: Strong Market Adoption and Promising Growth Trajectory with New Product Launches and Revenue Expansion TriSalus Life Sciences Reports Strong Q2 2025 Growth TriSalus Life Sciences reports Q2 EPS (27c), consensus (22c) PremiumCompany AnnouncementsTriSalus Launches Exchange Offer for Preferred Stock TriSalus Life Sciences management to meet virtually with Lake Street TriSalus Life Sciences Holds Annual Shareholder Meeting PremiumCompany AnnouncementsTrisalus Life Sciences Q1 2025 Earnings Call Highlights TriSalus Life Sciences: Strategic Developments and Revenue Growth Drive Buy Rating TriSalus Life Sciences management to meet virtually with Lake Street